anthracycline chemotherapy
Showing 26 - 50 of >10,000
Triple Negative Breast Cancer Trial (biological, drug, radiation)
Withdrawn
- Triple Negative Breast Cancer
- avelumab
- +17 more
- (no location specified)
Mar 17, 2021
Breast Cancer Trial in Damietta (L-Carnitine 500Mg Oral Tablet)
Completed
- Breast Cancer
- L-Carnitine 500Mg Oral Tablet
-
Damietta, Tanta City, EgyptHorus University
Jun 15, 2020
Neoadjuvant Chemotherapy in Breast Cancer
Completed
- Breast Cancer
- Mathematical modeling to predict response to chemotherapy
-
Albuquerque, New MexicoUniversity of New Mexico Comprehensive Cancer Center
May 11, 2021
Primary Breast Cancer Trial in Beijing (paclitaxel/anthracycline)
Active, not recruiting
- Primary Breast Cancer
-
Beijing, China
- +6 more
Nov 26, 2021
Cardiotoxicity, Osteosarcoma, Myocardial Injury Trial in Hangzhou (contrast-enhanced cardiac magnetic resonance imaging(MAGNETOM
Unknown status
- Cardiotoxicity
- +4 more
- contrast-enhanced cardiac magnetic resonance imaging(MAGNETOM Aera 1.5T)
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jul 2, 2020
Breast Cancer, Triple Negative Breast Tumors Trial in Sweden (epirubicin, cyclophosphamide, paclitaxel, carboplatin, epirubicin,
Recruiting
- Breast Cancer
- Triple Negative Breast Neoplasms
- epirubicin, cyclophosphamide, paclitaxel, carboplatin
- epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin
-
Borås, Sweden
- +15 more
Jan 3, 2022
Breast Cancer Trial in United States (KIBUR MICRODEVICE, anthracycline and taxane based chemo)
Active, not recruiting
- Breast Cancer
- KIBUR MICRODEVICE
- anthracycline and taxane based chemotherapy
-
Basking Ridge, New Jersey
- +5 more
Jun 20, 2022
Breast Cancer Trial in Ottawa (Feasibility study)
Unknown status
- Breast Cancer
- Feasibility study
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Apr 18, 2020
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
CINV Trial in Odense (Ondansetron, Placebo, Dexamethasone)
Ketotifen: asCardioprotective Agent in Breast Cancer Patients
Completed
- Breast Cancer
- Iron Chelation
- Ketotifen 1 MG
-
Damietta, Damiete Governonate, EgyptHorus University
Jun 15, 2020
Chemo-induced Alopecia Trial in Caen, Lille (standard cold cap, scalp-cooling technique)
Recruiting
- Chemotherapy-induced Alopecia
- standard cold cap
- scalp-cooling technique
-
Caen, France
- +1 more
Aug 21, 2023
Tumors Trial in San Diego (low dose CT)
Completed
- Neoplasms
- low dose CT
-
San Diego, CaliforniaUniversity of California San Diego Medical Center
Nov 1, 2022
Leukemia, Cardiac Toxicity Trial in Pessac (Echographic analysis of myocardial deformation in 2D strain)
Completed
- Leukemia
- Cardiac Toxicity
- Echographic analysis of myocardial deformation in 2D strain
-
Pessac, FranceService de Cardiologie et Maladies Vasculaires, Hopital du Haut
Feb 8, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +4 more
- Biospecimen Collection
- +9 more
- (no location specified)
Jun 26, 2023
Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)
Recruiting
- Doxorubicin Induced Cardiomyopathy
- Atorvastatin 40 Mg Oral Tablet
- Placebo
-
Cairo, EgyptAin Shams University hospitals
Apr 4, 2023
Acute Myeloid Leukemia, Adult, Cardiotoxicity, Endothelial Dysfunction Trial in Samara (History taking, Anthropometry, Complete
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- History taking
- +14 more
-
Samara, Samara Region, Russian FederationClinics of the Samara Medical University
Jan 26, 2023
HER2-negative Breast Cancer, Neoadjuvant Therapy, Pathological Complete Response Trial in Beijing (Camrelizumab with vinorelbine
Recruiting
- HER2-negative Breast Cancer
- +5 more
- Camrelizumab with vinorelbine and cisplatin
-
Beijing, Beijing, ChinaPeking University First Hospital
Oct 15, 2022
Triple Negative Breast Tumors Trial (Pembrolizumab, Nab-paclitaxel, Anthracycline (doxorubicin))
Completed
- Triple Negative Breast Neoplasms
- Pembrolizumab
- +5 more
- (no location specified)
Aug 21, 2020
Cancer Activity and Lifestyle Measurement Study
Active, not recruiting
- Breast Cancer
-
Columbus, OhioThe Ohio State University Clinical Research Center (Davis Medica
Aug 26, 2022
Cardiotoxicity, Childhood Cancer Trial in Montpellier (cardiac ultrasound with speckle tracking analysis)
Recruiting
- Cardiotoxicity
- Childhood Cancer
- cardiac ultrasound with speckle tracking analysis
-
Montpellier, FrancePediatric and Congenital Cardiology and Pulmonology Department,
Mar 23, 2023
HER2-negative Breast Cancer Trial in Chengdu (AT regimen, TP regimen)
Unknown status
- HER2-negative Breast Cancer
- AT regimen
- TP regimen
-
Chengdu, Sichuan, ChinaDepartment of breast surgery, Sichuan Provincial People's Hospit
Jul 30, 2020
Developing Cardiotoxicity After Receiving Chemotherapy for
Recruiting
- Breast Cancer
- +2 more
- Cardiac Imaging
- Data Collection
-
Montréal, Quebec, Canada
- +2 more
Dec 20, 2022
Breast Cancer, Lymphoma, Large B-Cell, Diffuse, Cardiotoxicity Trial in Rozzano (Nebivolol, Placebo)
Active, not recruiting
- Breast Cancer
- +4 more
- Nebivolol
- Placebo
-
Rozzano, Milan, ItalyIRCCS Humanitas Research Hospital
Feb 5, 2023